Clinical

Clinical  ·  Weekly Digest - 21 February to 27 February 2026
Bispecific ADC Iza-bren meets both primary endpoints, significantly improving PFS and OS in unresectable or advanced/metastatic triple-negative breast cancer post-taxane failure

Weekly Digest – February 2026 Weekly Digest – February 2026 24 February 2026: Bispecific ADC Iza-bren meets both primary endpoints, significantly improving PFS and OS in unresectable or advanced/metastatic triple-negative breast cancer post-taxane failure Sichuan Baili Tianheng Pharmaceutical announced that […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 21 February to 27 February 2026
IDEAYA Biosciences announces first-patient-in for Phase 1 trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific TOP1 ADC

Weekly Digest – February 2026 Weekly Digest – February 2026 25 February 2026: IDEAYA Biosciences announces first-patient-in for Phase 1 trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific TOP1 ADC IDEAYA Biosciences announced that the first patient has been enrolled […]

by Sandhya Ramalingam

Continue Reading